Clinical Trial Update: A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2b trial evaluating DIO-902 in addition to standard therapy for Type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIO-902 (DIO-902)
• atorvastatin (atorvastatin)
• metformin (metformin)

Snippet

Sponsor: DiObex | Conditions: Type 2 Diabetes | Phase 2 | Status: TERMINATED